Literature DB >> 32946794

Emerging roles of absent in melanoma 2 in cardiovascular diseases.

Zhan-Zhi Zhao1, Xi-Long Zheng2, Zhi-Sheng Jiang3.   

Abstract

Absent in melanoma 2 (AIM2) is a member of the PYHIN (pyrin and HIN domain-containing protein) family with important roles in sensing double-stranded DNA (dsDNA) and assembling the AIM2 inflammasome, which has wide-ranging, pro-inflammatory and pro-pyroptotic properties. The AIM2 inflammasome can become activated in atherosclerotic plaque, abdominal aortic aneurysm wall and injured myocardium, and its activation is tightly regulated by a variety of atherogenic factors. Activation of the AIM2 inflammasome has close links to the progression of several cardiovascular diseases. This review will summarize the current knowledge of AIM2 biology, providing the latest insights into the mechanisms and contributions of atherogenic factors to AIM2 inflammasome activation. In addition, we will also explore crosstalk between AIM2 and the pathologies of atherosclerosis, abdominal aortic aneurysm, myocardial infarction and heart failure. A better understanding of the pathological roles of AIM2 in these disorders will be helpful in developing novel therapeutic approaches.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Abdominal aortic aneurysm; Absent in melanoma 2; Absent in melanoma 2 inflammasome; Atherosclerosis; Heart failure; Myocardial infarction

Mesh:

Substances:

Year:  2020        PMID: 32946794     DOI: 10.1016/j.cca.2020.08.031

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  6 in total

1.  Contribution of the innate and adaptive immune systems to aortic dilation in murine mucopolysaccharidosis type I.

Authors:  Elizabeth Braunlin; Juan E Abrahante; Ron McElmurry; Michael Evans; Miles Smith; Davis Seelig; M Gerard O'Sullivan; Jakub Tolar; Chester B Whitley; R Scott McIvor
Journal:  Mol Genet Metab       Date:  2022-02-03       Impact factor: 4.204

2.  The Association of Serum AIM2 Level with the Prediction and Short-Term Prognosis of Coronary Artery Disease.

Authors:  Wenkang Zhang; Gaoliang Yan; Chunyang Xu; Chengchun Tang
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2022-05-14       Impact factor: 4.109

Review 3.  Emerging Roles of Inflammasomes in Cardiovascular Diseases.

Authors:  Yingnan Liao; Kui Liu; Liyuan Zhu
Journal:  Front Immunol       Date:  2022-04-07       Impact factor: 8.786

4.  AIM2 inhibits the proliferation, invasion and migration, and promotes the apoptosis of osteosarcoma cells by inactivating the PI3K/AKT/mTOR signaling pathway.

Authors:  Jianping Zheng; Changhao Liu; Jiandang Shi; Kun Wen; Xiangxin Wang
Journal:  Mol Med Rep       Date:  2021-12-16       Impact factor: 2.952

Review 5.  Novel Insights Into the Pathogenesis of Diabetic Cardiomyopathy and Pharmacological Strategies.

Authors:  Felipe Muñoz-Córdova; Carolina Hernández-Fuentes; Camila Lopez-Crisosto; Mayarling F Troncoso; Ximena Calle; Alejandra Guerrero-Moncayo; Luigi Gabrielli; Mario Chiong; Pablo F Castro; Sergio Lavandero
Journal:  Front Cardiovasc Med       Date:  2021-12-23

Review 6.  Pyroptosis and Its Regulation in Diabetic Cardiomyopathy.

Authors:  Yafang Lu; Yaqiong Lu; Jun Meng; Zuo Wang
Journal:  Front Physiol       Date:  2022-01-25       Impact factor: 4.566

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.